VivoSeq
Other

Parenteral Nutrition

0

Pipeline Programs↗

2

Active Trials↗

3

Companies Involved↗

Parenteral Nutrition is an early-stage landscape with 0 programs across 3 companies. The most active players are Fresenius, Sino-Swed Pharmaceutical Corporation, Fujian Shengdi Pharmaceutical Co., Ltd..

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

F

Fresenius

0 programs

PreclinicalS

Sino-Swed Pharmaceutical Corporation

0 programs

PreclinicalF

Fujian Shengdi Pharmaceutical Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

36

clinical trials

Completed22 · 61%
Unknown status8 · 22%
Terminated3 · 8%
Recruiting1 · 3%
Active, not recruiting1 · 3%
Withdrawn1 · 3%

Clinical Trials

Trial Activity

36 trials

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition
Recruiting·YYuhan Corporation·Phase 3·NCT06625957·60 enrolled
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
Active, not recruiting·EErasmus Medical Center·Phase 4·NCT04094038·166 enrolled
A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition
Completed·JJW Life Science·Phase 3·NCT01533766·50 enrolled
Intradialytic Parenteral Nutrition in Hemodialysis Patients
Completed·FFresenius·Phase 4·NCT00501956·140 enrolled
Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care
Completed·FFresenius·Phase 3·NCT05257031·56 enrolled
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
Completed·UUniversity of Texas·N/A·NCT00004697·15 enrolled
Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population
Completed·—·Phase 4·NCT02539316·9 enrolled
Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
Completed·KKing Faisal Specialist Hospital & Research Center·Phase 4·NCT02216799·61 enrolled
Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition
Completed·TThammasat University·Phase 3·NCT02663453·44 enrolled
Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition
Completed·YYuhan Corporation·Phase 3·NCT06625931·60 enrolled
Effect on Blood Chemistry and Inflammatory Marker of Omega-3 Enriched Total Parenteral Nutrition
Completed·—·Phase 4·NCT02468713·16 enrolled
Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition
Completed·FFresenius·Phase 3·NCT03792100·273 enrolled
Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
Completed·FFresenius·Phase 3·NCT00451646·75 enrolled
Effects of Parenteral Nutrition in HSCT
Completed·SSt. Petersburg State Pavlov Medical University·N/A·NCT04425642·120 enrolled
Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving Glutamine
Completed·IInstitute of Child Health·Phase 4·NCT00647036·60 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)